Robichon, Katharina
Sondhauss, Sven
Jordan, T. William
Keyzers, Robert A.
Connor, Bronwen
La Flamme, Anne C.
Funding for this research was provided by:
Ministry of Business, Innovation and Employment (RTVU1503)
Ministry of Business, Innovation and Employment (RTVU1503)
Article History
Received: 6 July 2020
Accepted: 14 January 2021
First Online: 3 February 2021
Competing interests
: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Anne Camille La Flamme and Bronwen Connor have a patent for the use of clozapine during multiple sclerosis. The other authors declare no competing interests.